CALGB 40503---Double blind placebo controlled Phase III trial of Endocrine therapy plus Bevacizumab for women with hormone receptor positive advanced breast cancer.
SO518--- Phase III Prospective Randomized Comparison of Depot Octreotide Plus Interferon Alpha vs Depot Octreotide Plus Bevacizumab in Advanced Poor Prognosis Carcinoid Patients.
E1505--- A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB-IIIA Non-Small Cell Lung Cancer.
Head & Neck Cancer
E1305--- Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer.
For more information on clinical trials, please call 606-833-3253.